Femasys Inc (FEMY) stock
FEMYNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 7/3035% below fair value
$1.15+0.03 (+2.68%)
Close on Nov 18, 2026Market cap $9.63MP/E –Yield –
Femasys gross profit
Gross profit is revenue minus the direct cost of the goods and services sold.
Femasys's gross profit for the twelve months ending Jun 30, 2026 was $1.40M, up 14.1% year over year. For fiscal 2025 it was $1.42M, up 31.1% from the year before. The highest annual figure on record is $1.42M in fiscal 2025.
Annual gross profit
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.42M | +31.1% |
| FY2024 | Dec 31, 2024 | $1.08M | +56.7% |
| FY2023 | Dec 31, 2023 | $691.90K | -9.5% |
| FY2022 | Dec 31, 2022 | $764.28K | -5.6% |
| FY2021 | Dec 31, 2021 | $809.31K | +10.7% |
| FY2020 | Dec 31, 2020 | $731.39K | – |
Quarterly gross profit
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $189.39K | -24.6% |
| Q1 FY2026 | Mar 31, 2026 | $266.28K | +18.9% |
| Q4 FY2025 | Dec 31, 2025 | $510.26K | +31.1% |
| Q3 FY2025 | Sep 30, 2025 | $435.56K | +19.6% |
| Q2 FY2025 | Jun 30, 2025 | $251.10K | +69.2% |
| Q1 FY2025 | Mar 31, 2025 | $224.00K | +22.7% |
| Q4 FY2024 | Dec 31, 2024 | $389.17K | +188.7% |
| Q3 FY2024 | Sep 30, 2024 | $364.07K | +130.2% |
| Q2 FY2024 | Jun 30, 2024 | $148.36K | -29.4% |
| Q1 FY2024 | Mar 31, 2024 | $182.61K | -3.3% |
| Q4 FY2023 | Dec 31, 2023 | $134.82K | -9.4% |
| Q3 FY2023 | Sep 30, 2023 | $158.18K | -26.8% |
| Q2 FY2023 | Jun 30, 2023 | $210.05K | +4.6% |
| Q1 FY2023 | Mar 31, 2023 | $188.86K | -5.0% |
| Q4 FY2022 | Dec 31, 2022 | $148.79K | -21.7% |
| Q3 FY2022 | Sep 30, 2022 | $216.01K | +31.6% |
| Q2 FY2022 | Jun 30, 2022 | $200.76K | -8.1% |
| Q1 FY2022 | Mar 31, 2022 | $198.73K | -16.1% |
| Q4 FY2021 | Dec 31, 2021 | $190.02K | -1.7% |
| Q3 FY2021 | Sep 30, 2021 | $164.18K | -26.3% |
| Q2 FY2021 | Jun 30, 2021 | $218.38K | +70.7% |
| Q1 FY2021 | Mar 31, 2021 | $236.73K | – |
| Q4 FY2020 | Dec 31, 2020 | $193.33K | – |
| Q3 FY2020 | Sep 30, 2020 | $222.77K | – |
| Q2 FY2020 | Jun 30, 2020 | $127.96K | – |
See a number that looks wrong?